Global Femtech Market

The Femtech Market Size was valued at USD 20.49 Billion in 2023 and the total Femtech revenue is expected to grow at a CAGR of 12.38 % from 2024 to 2030, reaching nearly USD 46.38 Billion by 2030

Femtech Market Overview

Femtech (Female Technology) is technology empowering women’s health and well-being. The term is often applied to products, services, applications and software, medical devices, telehealth, wearables, hardware, therapeutic drugs, vitamins and supplements, digital platforms, and consumer products designed to improve or support women's health.

To know about the Research Methodology:- Request Free Sample Report

1. According to MMR Analysis, 1,800+ companies in 75 countries while there were about 470 before 2015 in 40 countries. 51% Of Femtech companies are addressing menstruation, maternal health, fertility, and sexual wellness

Surged in women's health issues has been experiencing a higher demand in the Femtech Market in 2023. Women comprise 50% of the world’s population and 40% of the global workforce in 2023. Femtech covers a variety of technologies which covers the innovations in health technology for females, especially for feminine hygiene products has driven the market growth. As women are becoming more aware of general and sexual health their priorities are also changing. Femtech has been giving various opportunities through various apps, devices, and virtual clinics. The rise in the Femtech market is attributed to a combination of increased awareness, technological advancements, investment, and a growing demand for women's healthcare solutions. With the increasing prevalence of smartphones and wearable technology, it has become easier to track and monitor various health metrics, such as menstrual cycles and fertility, leading to the development of new Femtech products. Virtual clinics, direct-to-consumer prescription delivery services, and innovative physical clinics give women a more convenient, consumer-friendly way to access healthcare.

Femtech Market Dynamics

Driving Forces Behind the Surging Growth of the Femtech Market

The Femtech industry has witnessed significant growth in 2023, driven by a convergence of factors that underscore its importance in the healthcare and technology sectors. The feminist movement, rapid digitalization, and personalised healthcare have given a boost to its rapid development. The increasing use of digital technologies to address women's health as well as rising knowledge and acceptance of women's health issues has propelled the market growth. The growing prevalence of women-related diseases has accelerated the Femtech market. Additionally, advancements in digital health technologies, such as wearable devices and mobile apps, have empowered women to take charge of their health, further propelling the industry's growth.

Unlocking Opportunities in the Femtech Market

Every year, 60 million women have a vaginal infection, within a year, bacterial vaginosis (BV) has a 70% recurrence, followed by UTIs at 45% and yeast infections at 35% has created opportunities in the Femtech market. Emerging technologies such as tracking wearables, artificial intelligence, apps, and non-invasive hardware are being used to bring wider awareness to improving female health. Most companies develop solutions in five different elements such as infertility, motherhood, pregnancy, gynecological health, and lifestyle & wellness as a result the opportunities ensure greater public awareness and reduce barriers for Femtech entrepreneurs. The increased in Femtech companies are creating wearable wellness technology that integrates with smartphones. Rapid development in technologies offers data-driven approaches for managing women’s healthcare and allows women to take control of health-related data. A smart breast pump that tells its user when the milk container is full and automatically stops pumping has led to the demand in the market.

Navigating Growth Hurdles in the Femtech Market

Femtech companies have trouble raising funds from investors compared to other Health Tech (the healthcare technologies sector) start-ups. In low-income areas, the funding for services and product development is not that high as a result it hinders the market growth. Most females are not aware of this app and there is no knowledge related to technology has created a barrier in the Femtech market. As the capabilities of digital health technology increase, Femtech companies face additional legal risks when collecting and storing personal health information about their customers.

Femtech Market Segment Analysis

Based on Application, the Reproductive health Segment holds the highest market share at 21.30% with a growing CAGR of 7.78% during the forecast period. Thanks to the range of Femtech products being introduced in the Femtech market, women is able to identify the problem in the comfort of their homes and treat it. Diseases affecting reproductive systems are relatively common among women, particularly the ones of childbearing age. Most females are not able to take care of their initial period of pregnancy and want better access to services that empower health hands. Femtech focuses on delivering reproductive products for home use and also helps to track the period cycles on time. Women can improve their maternal outcomes, and overall wellness and make healthcare a more equitable place. The lower income areas also get the services in a proper manner and have free consultations related to pregnancy issues. Only 4% of R&D funds in the healthcare sector are aimed specifically at women’s health.

According to MMR Analysis, about 75% of the total Femtech market is made up of companies active in fertility, pregnancy, maternity, and contraception. The pregnancy and nursing subsector is the largest within the sector regarding the number of companies, accounting for 17.83% of the total Femtech market. Femtech start-ups with a B2C business model with 23% are increasingly turning to B2B2C with 26%.

Femtech Market Regional Insights

North America dominated the Femtech Market with the highest market share accounting for 54% in 2023, the region is expected to grow during the forecast period and maintain its dominance by 2030. North America dominates the global Femtech market by number of companies, accounting for 47.8%. The region is booming with new start-ups and research in women's health and wellness. The AI in Femtech platform is a central hub for the intersection of AI and women’s health. It showcases the profiles of 100 leaders, 170 companies, 390 investors, and 35 R&D centers actively involved in the Femtech Market. The increase in health awareness in which women exhibit a 75% higher likelihood of using digital healthcare tools compared to men in the region. Europe is second with 25.10%, followed by Asia Pacific with 14.90% and Middle East and Africa with 7%. The United States and the United Kingdom are the leading countries with the largest number of Femtech companies in the world. The maternal mortality rate is increasing, with the United States having the highest maternal mortality of all developed countries. The Femtech sector is expected to double in size to cover additional areas of women's healthcare and technology.

Femtech Market Competitive Landscape

1. In November 2023, Bayer and CrossBay Medical announced a partnership to develop a new intrauterine system inserter. The new inserter will have the aim of reducing the pain experienced by women during IUS insertion.

2. In November 2023, GE launched the MyBreastAi platform. The platform offers AI capabilities in mammography.

3. In October 2023, market player Femfeel was acquired by pharmaceutical giant MEDICE Health Family. By means of the acquisition, MEDICE Health Family entered the market.

Femtech Market Scope: Inquire before buying

Femtech Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Femtech Market Key Players

1. Ava Science Inc. California, USA
2. Elvie -United Kingdom
3. Nurx - USA
4. Natural- Cycles Sweden
5. Willow - Headquarters USA
6. Modern Fertility - USA
7. Femtech Collective - USA
8. Clue -Germany
9. Glow - USA
10. Kindara - USA
11. Ava Women - Switzerland
12. Inne - France
13. NextGen Jane - USA
14. Femometer - China
15. Daisy Intelligence - USA
16. Sustain Natural - USA
17. Future Family - USA
18. Maven Clinic - USA
19. Tia Clinic - USA
20. Lily Smart Birth Control - USA

Frequently Asked Questions:

1] What is the projected market size & and growth rate of the Femtech Market?
Ans. The Femtech Market size was valued at USD 20.49 Billion in 2023 and the total Femtech revenue is expected to grow at a CAGR of 12.38 % from 2024 to 2030, reaching nearly USD 46.38 Billion By 2030

2] What segments are covered in the Femtech Market report?
Ans. The segments covered in the Femtech Market report are based on Type, Product Type, and Application, End User.

3] Which region is expected to hold the highest share in the Femtech Market?
Ans. The North American region is expected to hold the highest share of the Femtech Market.

4] What are the growth drivers for the Femtech Market?
Ans. The rising demand for women healthcare awareness, etc. is expected to be the major driver for the Femtech Market.

5] What is the forecast period for the Femtech Market?
Ans. The forecast period for the Femtech Market is 2024-2030.